HLA-E and neoplasm: CD8+ tumor-infiltrating T lymphocytes with high PD-1 content are prevented from surviving in the tumor microenvironment by the interaction of enriched HLA-E and CD94/NKG2A inhibition (Abd Hamid et al., 2019).